secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2025-07-30T23:59:59+00:00
Accession:  0000950170-25-100341
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma reports exercise of pre-funded warrants for 2.08M shares of common stock
--------------------------------------------------------------------------------

- Investor exercised Pre-Funded Warrants to purchase 2,084,509 shares of common stock on July 24, 2025.
- Exercise price paid in cash was $208.45 in aggregate, representing a nominal per-share price.
- Warrants were issued under the PIPE Offering initially disclosed on July 17, 2025, with exercise price of $3.4199 per warrant.
- Shares were issued in reliance on Section 4(a)(2) and Rule 506(b) of Regulation D exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000095017025100341/0000950170-25-100341-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000095017025100341/meip-20250724.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-100341

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer